Astonishing results from the DanGer Shock Trial presented at #ACC24 and out in NEJM today.

In patients with ST-elevation MI with cardiogenic shock, Impella reduced all-cause mortality (45.8% Impella vs. 58.5% control) at 180 days.

Some thoughts on this ground breaking trial:

Please join OPCI @ #ACC24 this Saturday American College of Cardiology for hands on training with IVUS-NIRs in patients with CKD. Learn how to incorporate low contrast PCI into your practice. Great for fellows too! Allen Jeremias Ziad Ali
Akiko Maehara Rushi Parikh opci.events/V8LeqK

Very excited to be joining StanfordMedRes for residency! Thank you to my family, friends, and mentors, especially Rushi Parikh, Boback Ziaeian 🤦🏻‍♂️, and Murray Kwon, MD, MBA, for your unwavering support throughout this journey! #match2024 David Geffen School of Medicine at UCLA

Very excited for Priscilla Hsue to join us Department of Medicine at UCLA Health! She is truly a trailblazer and an invested mentor to many—looking forward to her leadership and vision!

A big shout out to Dr. Nick West, Associate CMO at Shockwave Medical, from UCLA Biodesign for joining us for an engaging Fireside Chat! Nick shared pearls on career “rocket fuel” & purpose, leadership, and traits of successful medtech innovators—thanks for these invaluable insights!

It’s moments like these when I think about people who don’t enjoy sports and I wonder what they’re doing right now. Maybe a nice book or museum or hike or something. All lovely, I’m sure.

Gimme this.

With the 🐐 𝐌𝐢𝐭𝐜𝐡 𝐀𝐥𝐛𝐨𝐦—LET’S GO LIONS!

Thank you to Dr. Justin Barad Justin Barad Founder/CEO of Osso VR for joining us for our winter Biodesign Fireside Chat at Wolfsglen last night with current fellows and alumni! With Dr. Rushi Parikh Rushi Parikh as moderator, we enjoyed hearing about Dr. Barad's startup journey

Great day advancing hypertension treatment! We did 2 commercial Spyral renal denervation cases for patients who have been struggling with BP control and mediation intolerance for years. Tears by both afterwards. Exciting times! BIDMC BIDMC CVI BIDMC Smith Center SCAI Now Hypertension

Proud to showcase work in the heart transplant population from our group led by star research mentees Jenny Yineen Chen and Negeen Shahandeh, MD (not pictured bc holding down the CCU fort!) at #UCLADoMResearchDay !

Department of Medicine at UCLA Health E. Dale Abel Gregg Fonarow MD Ali Nsair, MD Jeff Hsu, MD, PhD

Week 1 of 2023 UCLA Biodesign Bootcamp in the books! Special shout out to Nworah Ayogu, CMO/GM of Amazon Clinic, for doing an insightful and inspiring Fireside Chat with me covering Tech in healthcare, leadership, and figuring out your superpower!

Uncensored. Said it how it is. European Society of Cardiology Journals European Society of Cardiology

Five-year major cardiovascular events are increased when coronary revascularization is guided by iFR compared to FFR: a pooled analysis of iFR-SWEDEHEART and DEFINE-FLAIR trials.
academic.oup.com/eurheartj/adva…

#iFR #FFR #physiology #outcome #ESC2023 European Society of Cardiology European Society of Cardiology Journals

Donor-transmitted CAD after heart transplantation may occur in as many as 1 in 5 pts but doesn't seem to affect survival in those well enough to undergo angiography within the first 3 mos post-transplant, according to new data.

tctmd.com/news/cad-donor… David Couto Mallón Rushi Parikh

Check out our rare case of a 14 y/o w/ COVID-induced MIS-C who p/w giant LAD aneurysm c/b STEMI 😱🤯!Congrats to @realjaympatel for leading this effort and MyJSCAI for publishing our work.
UCLA Cardiology Fellowship Olcay Aksoy

Intravascular imaging guidance for percutaneous coronary intervention associated with improved outcomes, though use in US remains infrequent. Reza Fazel Robert W. Yeh MD David J. Cohen, MD, MSc Sunil V. Rao Eric Secemsky MD MSc et al in EHJ Editor-in-Chief: academic.oup.com/eurheartj/adva…

BIDMC CVI

A week ago, our 2022-2023 Biodesign fellows showcased their pitches at our graduation ceremony! We have had such an amazing cohort of Discovery, Accelerator, and Translational Biodesign fellows this year, please join us in congratulating them! #uclahealth #uclabiodesign #medtech

>4 years after the Katsanos meta-analysis & the PTX controversy comes to an end. Proud professional moment to have contributed to navigating this controversy. Congrats to U.S. FDA FDA Medical Devices for getting this right. This important case will be remembered.shorturl.at/rzVY7

Join us tomorrow, June 28th, for Biodesign Fellow Graduation from 10AM-12PM!
In-person RSVP: bit.ly/3CKcuEJ
Virtual RSVP: bit.ly/44fSwgO

After registering for the webinar, you will receive a confirmation email with details #innovation #biodesign #uclahealth

Join UCLA Biodesign in celebrating the graduation of the 2022-2023 Biodesign Fellows! The session will showcase pitches from our fellows and include a keynote address by Artie Southam, MD, former executive VP, Health Plan Operations, and chief growth officer for Kaiser Permanente